NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PathogenDx Applauded by Frost & Sullivan for its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test - PathogenDx’s disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains - PathogenDx.com / Frost.com
PathogenDx Applauded by Frost & Sullivan for its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test

 

NewswireToday - /newswire/ - Scottsdale, AZ, United States, 2021/03/22 - PathogenDx’s disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains - PathogenDx.com / Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the global molecular testing market, Frost & Sullivan recognizes PathogenDx, Inc. with the 2021 Global Technology Innovation Leadership Award for its DetectX-Rv and EnviroX-Rv tests. PathogenDx adapted its unique testing platform by combining multiplexed end-point, real-time polymerase chain reaction (RT-PCR) with DNA microarray technology to enable testing for COVID-19 in people, in the air, and on contact surfaces. The DETECTx–Rv utilizes nasopharyngeal swabs, nasal aspirate or fluids, and viral RNA isolation kits and contains more probes on its microarray to drive 100% specificity in the test.

“PathogenDx’s testing technology harnesses all the different historical mutations and evolves to add the necessary probes quickly within three to four weeks, capturing new mode mutations without a significant linear cost increase,” said Daniel Ruppar, Consulting Director at Frost & Sullivan. “With an ultra-rapid sample-to-result testing turnaround time of four and a half hours, PathogenDx aims to simplify and expedite COVID-19 detection. Its novel platform enhances COVID-19 detection accuracy and efficacy without compromising sensitivity and specificity so users can diagnose low viral load transmission and limit infection spread.”

The company’s DetectX-Rv can triage patients by distinguishing among several other flu-like symptoms, such as cold and influenza A and B, from COVID-19. The test complements this accuracy with high throughput, offering 96 tests per kit. PathogenDx is looking to scale and maximize the throughput by enabling pooled sample testing to accommodate up to 3,456 tests on six plates of the 96-well microarray and deploy continuous processing manually with four lab technicians or through automation. Furthermore, PathogenDx’s test applies its One-step PCR that maximizes DNA amplification using similar amplification technologies, such as next-generation sequencing or Droplet Digital-PCR, leading to 10 times better accuracy than with other FDA-approved PCR-based tests.

Furthermore, PathogenDx provides its environmental screening and monitoring EnviroX-Rv test for public facilities and buildings lacking ventilation. The test can detect viruses that spread through transmitted droplets and that remain either air-suspended for hours or on surfaces for up to three days. With at least 10 times more sensitivity than existing virus-detecting technologies and with a threshold detection limit of 62 copies of the virus, EnviroX-Rv delivers 98% accuracy and detects minimal viral load, which is as low as a single copy.

“While the DetectX-Rv allows qualitative viral detection and management with a rapid result turnaround time, the EnviroX-Rv test screens airborne and surface-based COVID-19 transmissions at commercial facilities, leading to rapid sanitization,” noted Supriya Kundu, Best Practices Research Analyst at Frost & Sullivan. “Their matchless sensitivity, speed, and throughput are playing a huge role in driving preventive measures and improving safety.”

Each year, Frost & Sullivan presents this award to the company that demonstrates uniqueness in developing and leveraging new technologies that deliver significant customer value.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify the industry’s best practices.

About Frost & Sullivan

For six decades, Frost & Sullivan (frost.com) has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.

About PathogenDx

Headquartered in Scottsdale, Arizona, PathogenDx’s mission (pathogendx.com) is to become the new standard in DNA-based testing through widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries. PathogenDx’s technology can rapidly identify and detect up to 50 pathogens all in a single test, in 6 hours providing triplicate data per analyte for certainty in results with a simple and easy process. The company’s DNA-testing products DetectX™, QuantX™, and EnviroX™ are disrupting conventional microbial and molecular technologies to identify, detect and quantify pathogens that are a threat to human health, their ecosystem and the environment. This technology will help growing businesses deliver safer products and healthier lives, while preventing billions of dollars in losses from infection and contamination.

Media Contact
MATTIO Communications
pathogendx[.]mattio.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


PathogenDx Applauded by Frost & Sullivan for its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Claudia Toscano - Frost.com 
210-477-8417 claudia.toscano[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife
Laboratorios Inibsa Selects TrackWise Digital to Accelerate its Digital Quality Journey
Bruker Enters Partnership with Cambridge Isotope Laboratories to Further Strengthen LabScape® Portfolio of NMR Solutions
Tripp Lite Introduces New Hospital-Grade UV Charging Stations
Gentex Applauded by Frost & Sullivan for its Comprehensive Powered Air Purifying Respiratory Solution Suite PureFlo 3000
Cardiology Prepared for the Fourth Dimension
Withings Health Solutions Launches Cellular Devices to Eliminate Telehealth Pain Points for Healthcare Professionals and Patients
ScImage Lauded by Frost & Sullivan for its Cloud-based Enterprise Imaging Platform, PICOM365
RapidAI Acclaimed by Frost & Sullivan for its AI-powered Modular Stroke Platform
Belgian Initiative for AI Lung Scan Analysis in Fight Against COVID-19 Goes European
EyeQue Acclaimed by Frost & Sullivan for its Wide Range of Consumer-friendly, Hand-held Ophthalmic Monitoring Solutions
Withings Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
RapidAI Receives 2020 Global Company of the Year Award from Frost & Sullivan for its AI-Powered Stroke Imaging and Diagnosis Technologies
Withings Partners with Redox to Make Remote Patient Monitoring Seamless for Physicians and Hospitals
GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  SlideUpLift





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)